Skip to main content
SpringerLink
Log in

Endokrinologische Aspekte maligner Melanome

  • Chapter
Malignes Melanom

  • 16 Accesses

Zusammenfassung

Während der vergangenen zehn Jahre hat es ein erneutes Interesse an der vermuteten Rolle hormoneller Einflüsse auf die Prognose des cutanen Melanoms gegeben. Eine Reihe von Beobachtungen legen die Annahme nahe, daß gewisse Faktoren wie beispielsweise das Geschlecht des Patienten oder das Vorliegen einer Gravidität möglicherweise das biologische Verhalten dieses Tumors beeinflussen. In den letzten Jahren sind zahlreiche Veröffentlichungen erschienen, in denen offensichtliche Vorteile oder aber eine vollständige Wirkungslosigkeit endokriner Therapiemaßnahmen beim Melanom mitgeteilt wurden, ohne daß dabei verbindliche Schlußfolgerungen hätten angestellt werden können.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Allen AC, Spitz S (1953) Malignant melanoma; a clinicopathological analysis of the criteria for diagnosis and prognosis. Cancer 6:1 - 45

    Article  PubMed  CAS  Google Scholar 

  2. Allen EP (1955) Malignant melanoma; spontaneous regression after pregnancy. Br Med J 2:1067

    Article  PubMed  CAS  Google Scholar 

  3. Bodenham DC, Hale B (1972) Malignant melanoma. In: Stoll BA (ed) Endocrine therapy in malignant disease. Saunders, London, pp 377–383

    Google Scholar 

  4. Byrd BF, McGanity WJ (1954) The effect of pregnancy on the clinical course of malignant melanoma. South Med J 47:196 - 200

    Article  PubMed  Google Scholar 

  5. Conybeare RC (1964) Malignant melanoma and pregnancy; report of 3 cases. Obstet Gynecol 24:451–454

    PubMed  CAS  Google Scholar 

  6. Creagan ET, Ingle JN, Woods JE et al. (1980) Estrogen receptors in patients with malignant melanoma. Cancer 46:1785–1786

    Article  PubMed  CAS  Google Scholar 

  7. Creagan ET, Ingle JN, Green SJ et al. (1980) Phase II study of tamoxifen in patients with disseminated malignant melanoma. Cancer Treat Rep 64:199–201

    PubMed  CAS  Google Scholar 

  8. Creagan ET, Ingle JN, Ahmann DL etal. (1982) Phase II study of high dose tamoxifen (NSC-180 973) in patients with disseminated malignant melanoma. Cancer 49:1353–1354

    Article  PubMed  CAS  Google Scholar 

  9. Fisher RI, Neifeld JP, Lippman ME (1976) Oestrogen receptors in human malignant melanoma. Lancet 11:337–339

    Article  Google Scholar 

  10. Furnival CM, Cough IR, Thynne GSJ (1981) Malignant melanoma; tamoxifen and oestrogen receptors. Lancet 11:374–375

    Article  Google Scholar 

  11. Grill HJ, Benes P, Manz B etal. (1982) Steroid hormone receptors in human melanoma. Arch Dermatol Res 272:97–101

    Article  PubMed  CAS  Google Scholar 

  12. Herbst WP (1943) Malignant melanoma of the choroid with extensive metastases treated by removing secreting tissue of the testicles. J Am Med Assoc 122:597

    Google Scholar 

  13. Hersey P, Morgan G, Stone DE etal. (1977) Previous pregnancy as a protective factor against death from melanoma. Lancet 1:451–452

    Article  PubMed  CAS  Google Scholar 

  14. Hodgins MB (1983) Steroid hormones, receptors and malignant melanoma. In: MacKie RM (ed) Malignant melanoma; advances of a decade. Pigment cell, vol VI. Karger, Basel 1983, pp 116–126

    Google Scholar 

  15. Karakousis CP, Lopez RE, Bhakoo HS etal. (1980) Estrogen and progesterone receptors and tamoxifen in malignant melanoma. Cancer Treat Rep 64:819–827

    PubMed  CAS  Google Scholar 

  16. Magnus K (1977) Prognosis in malignant melanoma of the skin; significance of stage of disease, anatomical site, sex, age and period of diagnosis. Cancer 40:389–397

    Article  PubMed  CAS  Google Scholar 

  17. McCarty KS jr, Wortman J, Stowers S et al. (1980) Sex steroid receptor analysis in human melanoma. Cancer 46:1463–1470

    Article  PubMed  Google Scholar 

  18. McCarty KS jr, Paull DE, McCarty KS sr (1982) Hormonal aspects of melanoma. In: Seigler HF (ed) Clinical management of melanoma. Developments in oncology, vol V. Martinus Nijhoff, The Hague, pp 355–380

    Google Scholar 

  19. Meyskens FL, Voakes JB (1980) Tamoxifen in metastatic malignant melanoma. Cancer Treat Rep 64:171–173

    PubMed  Google Scholar 

  20. Mouly R, Dufourmentel C, Glicenstein J (1966) M61anome malin et grossesse. Bull Soc Franc Derm Syphil 73:661–666

    Google Scholar 

  21. Neifeld JP, Lippman ME, Fisher RI (1976) Receptors for steroid hormones in human melanoma. Surg Forum 27:108–110

    PubMed  CAS  Google Scholar 

  22. Nesbit RA, Woods RL, Tattersall MHN et al. (1979) Tamoxifen in malignant melanoma. N Engl J Med 301:1241–1242

    PubMed  CAS  Google Scholar 

  23. Olsen G (1966) The malignant melanoma of the skin. Acta Chir Scand [Suppl] 365:1–222

    CAS  Google Scholar 

  24. Pawelek JM (1976) Factors regulating growth and pigmentation of melanoma cells. J Invest Dermatol 66:201–209

    Article  PubMed  CAS  Google Scholar 

  25. Pondes S, Hunter JAA, White H etal. (1981) Cutaneous malignant melanoma in South-East Scotland. Q J Med 50:103–121

    PubMed  CAS  Google Scholar 

  26. Posey LE, Krementz ET (1983) The role of neuro-endocrine factors in human malignant melanoma. In: Costanzi JJ (ed) Malignant melanoma 1. Cancer Treatment and research, vol IX. Martinus Nijhoff, The Hague, pp 195–206

    Chapter  Google Scholar 

  27. Rampen FHJ (1980) Malignant melanoma; sex differences in survival after evidence of distant metastasis. Br J Cancer 42:52–57

    Article  PubMed  CAS  Google Scholar 

  28. Rampen FHJ, Mulder JH (1980) Malignant melanoma, an androgen-dependent tumour? Lancet 1:562–566

    Article  PubMed  CAS  Google Scholar 

  29. Rampen FHJ (1984) Sex differences in survival from cutaneous melanoma. Int J Dermatol 23:444–452

    PubMed  CAS  Google Scholar 

  30. Riimke P, Persijn JP, Korsten CB (1980) Oestrogen and androgen receptors in melanoma. Br J Cancer 41:652–656

    Article  Google Scholar 

  31. Sadoff L, Winkley J, Tyson S (1973) Is malignant melanoma an endocrine-dependent tumor? Oncology 27:244–257

    Article  PubMed  CAS  Google Scholar 

  32. Shaw HM, Milton GW, Farago GA etal. (1978) Endocrine influences on survival from malignant melanoma. Cancer 42:669–677

    Article  PubMed  CAS  Google Scholar 

  33. Shaw HM, McGovern VJ, Milton GW et al. (1980) Histologic features of tumors and the female superiority in survival from malignant melanoma. Cancer 45:1604–1608

    Article  PubMed  CAS  Google Scholar 

  34. Shaw HM, McGovern VJ, Milton GW et al. (1980) Malignant melanoma; influence of site of lesion and age of patient in the female superiority in survival. Cancer 46:3731–3735

    Article  Google Scholar 

  35. Shaw HM, McGovern VJ, Milton GW etal. (1982) The female superiority in survival in clinical stage II cutaneous malignant melanoma. Cancer 49:1941–1944

    Article  PubMed  CAS  Google Scholar 

  36. Shiu MH, Schottenfeld D, Maclean B etal. (1976) Adverse effect of pregnancy on melanoma; a reappraisal. Cancer 37:181–187

    Article  PubMed  CAS  Google Scholar 

  37. Skov-Jensen T, Hastrup J, Lambrethsen E (1966) Malignant melanoma in children. Cancer 19:620–626

    Article  PubMed  CAS  Google Scholar 

  38. Zava DT, Goldhirsch A (1983) Estrogen receptor in malignant melanoma: fact or artefact? Eur J Cancer Clin Oncol 19:1151–1159

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. F. H. J. Rampen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Rümke
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Hämatologisch-Onkologische Praxis Altona, Max-Brauer-Allee 52, D-2000, Hamburg 50, Deutschland

    Holger Voigt  & Ulrich R. Kleeberg  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Rampen, F.H.J., Rümke, P. (1986). Endokrinologische Aspekte maligner Melanome. In: Voigt, H., Kleeberg, U.R. (eds) Malignes Melanom. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-70460-4_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-70460-4_14

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-70461-1

  • Online ISBN: 978-3-642-70460-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation